Related references
Note: Only part of the references are listed.A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Gavin Giovannoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
G. Comi et al.
LANCET (2008)
Intravenous immunoglobulin in relapsing-remitting multiple sclerosis - A dose-finding trial
F. Fazekas et al.
NEUROLOGY (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clinical outcome measures in multiple sclerosis
Maria Pia Amato et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis
Judith Haas et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Oral fingolimod (FTY720) for relapsing multiple sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis
N Koch-Henriksen et al.
NEUROLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study
M Filippi et al.
LANCET NEUROLOGY (2006)
Prospective assessment of changing from placebo to IFN beta-1a in relapsing MS: The PRISMS study
J Oger et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Randomized study of once-weekly interferon beta-1a therapy in relapsing multiple sclerosis: three-year data from the OWIMS study
MS Freedman et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
A controlled trial of natalizumab for relapsing multiple sclerosis.
DH Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
No difference in efficacy of two different doses of intravenous immunoglobulins in MS: clinical and MRI assessment
M Lewanska et al.
EUROPEAN JOURNAL OF NEUROLOGY (2002)
A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS
E Bech et al.
NEUROLOGY (2002)
Ingested IFN-α -: Results of a pilot study in relapsing-remitting MS
SA Brod et al.
NEUROLOGY (2001)
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis
G Comi et al.
ANNALS OF NEUROLOGY (2001)
Share Paper
